Physician profile
Michelle Daill
NPI 1194785733
$1,852.93
in general payments reported to CMS, 2019-2025
20 companies · $508 in 2025
The $508 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $122 · 2021: $202 · 2022: $231 · 2023: $350 · 2024: $211 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,069.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $447.06 | 2022-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $203.24 | 2019-2025 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $192.95 | 2020-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Sanofi Pasteur INC. | $174.91 | 2019-2024 | |
| Cranial Technologies, INC | $167.57 | 2021-2025 | Doc Band |
| Pfizer INC. | $111.89 | 2023-2025 | |
| Kaleo, INC. | $81.04 | 2019-2021 | |
| Adlon Therapeutics L.P. | $78.03 | 2020-2021 | |
| Glaxosmithkline, LLC. | $70.59 | 2020-2023 | Pediarix, Bexsero |
| Corium, LLC | $68.59 | 2023 | Azstarys |
| Ironshore Pharmaceuticals INC. | $49.38 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $48.06 | 2019-2022 | |
| Neos Therapeutics, Lp | $34.43 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.61 | 2025 | |
| Biomarin Pharmaceutical INC. | $23.45 | 2025 | Voxzogo 1.2mg |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $20.27 | 2019 | |
| Vertical Pharmaceuticals, LLC | $18.50 | 2025 | Relexxii |
| Greer Laboratories, INC. | $15.75 | 2019 | |
| Phadia US INC. | $12.06 | 2020 | |
| Shire North American Group INC | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Daill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.